Corporate expenses 0.2 1.8 1.7 3.8
Total $0.3 $3.3 $2.4 $7.7
B) A special item -- further described in Note 2 above -- relating to
a Medicare cost report settlement of $1.9 million for fiscal 2006,
was reflected in the Home Health segment.
Excluding the items described in Notes 6A and 6B above, EBITDA for the
fourth quarters of 2007 and 2006 would have been $25.6 million and
$22.3 million, respectively, and for fiscal 2007 and 2006 would have
been $102.1 million and $75.1 million, respectively.
7) Depreciation and amortization reflected amortization of identifiable
intangible assets of $1.0 million and $3.9 million, respectively, for
the fourth quarter and fiscal 2007, and $0.9 million and $3.3 million,
respectively, for the fourth quarter and fiscal 2006.
8) Interest expense, net, included interest expense on a term loan, fees
associated with a $75 million revolving credit facility and
amortization of debt financing costs, net of interest income.
9) The Company's effective tax rate was 37.4% and 40.9% for the fourth
quarter and fiscal 2007, respectively, and 35.9% and 36.4% for the
fourth quarter and fiscal 2006, respectively. The impact of the
adoption of SFAS 123(R) resulted in an increase in the Company's
effective tax rate of 2.0% and 2.3% in the fourth quarter and fiscal
2007, respectively, and 3.8% and 3.5% in the fourth quarter and fiscal
2006, respectively. In addition, the recognition of state net
operating loss carryforwards and the release of certain tax reserves
resulted in decreases in the Company's effective tax rate of 4.3% and
1.6% in the fourth quarter and fiscal 2
'/>"/>
| SOURCE Gentiva Health Services, Inc. Copyright©2008 PR Newswire. All rights reserved |